IMR Press / RCM / Volume 23 / Issue 4 / DOI: 10.31083/j.rcm2304136
Open Access Review
Cardiac manifestations in hyperthyroidism
Show Less
1 Escuela de medicina, Universidad del Bosque, Fundación Cardioinfantil, 110131 Bogota, Colombia
2 Escuela de medicina y ciencias de la salud, Universidad del Rosario, Fundación Cardioinfantil, 110131 Bogota, Colombia
3 Escuela de medicina, Universidad Pontificia Bolivariana, Cardio-VID Clinic, 050010 Medellin, Colombia
4 Departamento de cardiología, Cardio-VID Clinic, 050010 Medellin, Colombia
5 Programa de falla cardiaca, Cardio-VID Clinic, 050010 Medellin, Colombia
6 Escuela de medicina y ciencias de la salud, Universidad del Rosario, Fundación Cardioinfantil, 110131 Bogota, Colombia
7 Centro de Investigación Biomédica Universidad de La Sabana (CIBUS), Fundación Cardioinfantil, 110131 Bogota, Colombia
8 Departamento de electrofisiología, Centro Internacional de Arritmias, Fundación Cardioinfantil, 110131 Bogota, Colombia
*Correspondence: josed.cruz@urosario.edu.co (José David Cruz)
Academic Editors: Emma Robinson and Michael Henein
Rev. Cardiovasc. Med. 2022, 23(4), 136; https://doi.org/10.31083/j.rcm2304136
Submitted: 27 September 2021 | Revised: 23 December 2021 | Accepted: 29 December 2021 | Published: 11 April 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Thyroid hormones have a fundamental impact on cardiac function that is mediated by genomic and nongenomic effects, alterations that condition physiological repercussions that lead to changes in frequency, contractility, rhythm and cardiac output as well as an increase in the incidence and prevalence of different cardiovascular diseases. This document presents an updated review of the implications that hyperthyroidism has in different cardiac conditions, including its importance in the evaluation of perioperative cardiovascular risk.

Keywords
hyperthyroidism
cardiovascular disease
heart failure
Figures
Fig. 1.
Share
Back to top